Palmitoyl tripeptide – 1 is a powerful skin-care ingredient to combat ageing, but like most skin-care ingredients it works more effectively when used in combination with other anti-ageing peptide ingredients. routine, It can help skin repair damage by stimulating collagen production for smoother and stronger skin.
Benefits:
- Collagen Production and Skin Firmness: Palmitoyl Tripeptide-1 is known for its role in stimulating collagen synthesis. Collagen is essential for skin elasticity and firmness. By promoting collagen production, this peptide helps in maintaining skin suppleness, reducing the appearance of fine lines, and improving skin texture. The various forms of peptides act upon collagen found in the body and particularly the skin. The most abundant form of collagen in the body is type collagen I, which is the collagen primarily responsible for repairing the skin. Collagen type III is found alongside collagen type I and works much in the same way, though it is not as tough as collagen I. Palmitoyl Tripeptide–1 mimics the relationship between the growth factors involved in the skin’s healing process and the production of collagen. Essentially, Palmitoyl Tripeptide-1 tricks the skin into producing more collagen to repair the skin, improve elasticity and minimise the appearance of fine lines and wrinkles.
- Skin Repair and Renewal: This peptide aids in skin repair and renewal by supporting cellular turnover. The enhanced renewal process contributes to a smoother skin surface, diminishing the appearance of uneven skin tone and promoting a more radiant complexion.
- Anti-Ageing Effects: Through its collagen-boosting properties, Palmitoyl Tripeptide-1 helps address signs of ageing, such as fine lines and wrinkles. Its action on collagen synthesis assists in improving skin firmness, contributing to a more youthful-looking complexion.
Sources
https://www.mdpi.com/2079-9284/4/2/16#B16-cosmetics-04-00016
https://www.mdpi.com/2079-9284/4/2/16/html
https://www.mdpi.com/2079-9284/4/2/16/html https://farma.com.ro/articles/2021.3-4/RJPhP_2021_3-4_Art-01.pdf https://pubmed.ncbi.nlm.nih.gov/18503476/
